How the Kidney Health Initiative Catalyzes Innovation in a Dynamic Environment

The future of the artificial kidney

“…The paradigm in the management of ESRD has changed from “disease-centered” to “patient-centered” with patient choices, and QoL playing an essential role in decision making. [ 13 ] Figure 2 shows the traditional and potential future management pathways in ESRD. The developments and the likely order in which these will translate to clinical use are in these four areas – enhanced dialysis, portable and WAK, bio-hybrid and IAK, and regenerative medicine and kidney components.…”

“…It is an internationally-oriented, multidisciplinary approach to involve clinicians, patients, researchers, regulators, technology engineers, and investors, to channelize research and industry toward finding solutions to technical and market challenges in a focused priority-driven manner. [ 13 47 ] US-FDA has granted devices such as WAK™ for HD and iBAK expedited access pathways under KHI.…”